Senti Biosciences (SNTI) Institutional Ownership $1.53 -0.01 (-0.65%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$1.56 +0.03 (+2.29%) As of 08/14/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Senti Biosciences (NASDAQ:SNTI)CurrentInstitutional OwnershipPercentage25.73%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$7.86MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$17.35M Get SNTI Insider Trade Alerts Want to know when executives and insiders are buying or selling Senti Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNTI Institutional Buying and Selling by Quarter Senti Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025Armistice Capital LLC892,207$1.88M0.0%N/A3.411% 8/8/2025 Geode Capital Management LLC147,314$311K0.0%+395.6%0.565% 5/15/2025Nantahala Capital Management LLC888,000$2.98M0.1%N/A3.405% 5/15/2025Heights Capital Management Inc.750,000$2.52M1.3%N/A2.876% 2/13/2025Renaissance Technologies LLC51,600$181K0.0%N/A1.071% 2/11/2025 Virtu Financial LLC13,356$47K0.0%N/A0.277% 11/14/2024NEA Management Company LLC442,615$1M0.1%-90.0%9.664% 11/7/2024 8VC GP I LLC253,755$573K0.8%-90.0%5.541% 10/31/2024 ARK Investment Management LLC176,666$399K0.0%-88.9%3.858% 7/26/2024 ARK Investment Management LLC1,585,772$438K0.0%-2.8%34.624% Get the Latest News and Ratings for SNTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/12/2024 8VC GP I LLC2,537,558$1.68M1.7%N/A5.697% 1/17/2024 ARK Investment Management LLC1,969,860$1.30M0.0%+7.9%4.423% 10/27/2023 TD Asset Management Inc241,208$102K0.0%+88.4%0.542% 9/7/2023Triatomic Management LP300,533$188K0.2%+42.5%0.675% 7/10/2023 ARK Investment Management LLC1,829,815$1.15M0.0%-3.8%4.143% 5/3/2023Triatomic Management LP210,883$249K0.2%+39.0%0.477% 4/17/2023 ARK Investment Management LLC1,901,467$2.24M0.0%-1.3%4.305% 2/14/2023Triatomic Management LP151,675$214K0.2%+168.7%0.346% 2/13/2023Artal Group S.A.55,555$78K0.0%-94.7%0.127% 2/7/2023 TD Asset Management Inc118,292$167K0.0%-12.3%0.270% 1/24/2023 ARK Investment Management LLC1,925,827$2.72M0.0%-7.8%4.391% 11/15/2022Triatomic Management LP56,454$123K0.1%N/A0.129% 11/7/2022 TD Asset Management Inc.134,892$285K0.0%+53.8%0.308% 11/3/2022The Manufacturers Life Insurance Company117,707$248K0.0%N/A0.269% 10/17/2022 ARK Investment Management LLC2,087,696$4.53M0.0%N/A4.771% 8/11/2022Artal Group S.A.1,055,555$2.07M0.1%N/A4.450% 8/8/2022 Allen Operations LLC21,443$42K0.0%N/A0.090% 8/4/2022 TD Asset Management Inc.87,696$172K0.0%N/A0.370% 7/29/2022Kingfisher Capital LLC113,163$222K0.1%N/A0.477% (Data available from 1/1/2016 forward) SNTI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNTI shares? During the previous two years, 11 institutional investors and hedge funds held shares of Senti Biosciences. The most heavily invested institutionals were Nantahala Capital Management LLC ($2.98M), Heights Capital Management Inc. ($2.52M), Armistice Capital LLC ($1.88M), NEA Management Company LLC ($1M), 8VC GP I LLC ($573K), ARK Investment Management LLC ($399K), and Geode Capital Management LLC ($311K).Learn more on Senti Biosciences' institutional investors. What percentage of Senti Biosciences' stock is owned by institutional investors? 25.73% of Senti Biosciences' stock is owned by institutional investors. Learn more on SNTI's institutional investor holdings. Which institutional investors have been buying Senti Biosciences' stock? Of the 10 institutional investors that purchased Senti Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: 8VC GP I LLC ($2.54M), Armistice Capital LLC ($892.21K), Nantahala Capital Management LLC ($888K), Heights Capital Management Inc. ($750K), ARK Investment Management LLC ($143.79K), Geode Capital Management LLC ($117.59K), and TD Asset Management Inc ($113.17K). How much institutional buying is happening at Senti Biosciences? Institutional investors have bought a total of 2,712,751 shares in the last 24 months. This purchase volume represents approximately $7.86M in transactions. Which of Senti Biosciences' major shareholders have been selling company stock? The following institutional investors have sold Senti Biosciences stock in the last 24 months: NEA Management Company LLC ($3.98M), 8VC GP I LLC ($2.28M), and ARK Investment Management LLC ($1.41M). How much institutional selling is happening at Senti Biosciences? Institutional investors have sold a total of 7,676,445 shares in the last 24 months. This volume of shares sold represents approximately $17.35M in transactions. Related Companies Rapt Therapeutics Major Shareholders Aclaris Therapeutics Major Shareholders Instil Bio Major Shareholders Cardiff Oncology Major Shareholders Lifevantage Major Shareholders Journey Medical Major Shareholders SELLAS Life Sciences Group Major Shareholders Black Diamond Therapeutics Major Shareholders BioAge Labs Major Shareholders Greenwich LifeSciences Major Shareholders This page (NASDAQ:SNTI) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access